Simulations Plus (NASDAQ:SLP) Shares Gap Down to $47.54

Shares of Simulations Plus, Inc. (NASDAQ:SLP) gapped down prior to trading on Friday . The stock had previously closed at $47.54, but opened at $46.16. Simulations Plus shares last traded at $46.91, with a volume of 34,220 shares.

Analyst Ratings Changes

Separately, Craig Hallum boosted their price objective on shares of Simulations Plus from $50.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, January 4th.

Simulations Plus Trading Up 0.3 %

The stock has a market capitalization of $952.57 million, a PE ratio of 90.00 and a beta of 0.72. The stock has a 50 day moving average price of $41.66 and a 200-day moving average price of $40.47.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. The company had revenue of $18.31 million for the quarter, compared to the consensus estimate of $17.31 million. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. Simulations Plus’s revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.20 earnings per share. Research analysts forecast that Simulations Plus, Inc. will post 0.67 earnings per share for the current year.

Simulations Plus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 6th. Investors of record on Monday, April 29th will be issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date is Friday, April 26th. Simulations Plus’s payout ratio is 45.28%.

Insider Buying and Selling at Simulations Plus

In related news, Director Walter S. Woltosz sold 18,945 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $38.02, for a total value of $720,288.90. Following the transaction, the director now directly owns 3,641,250 shares of the company’s stock, valued at approximately $138,440,325. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $39.94, for a total value of $798,800.00. Following the completion of the transaction, the director now owns 3,600,195 shares in the company, valued at $143,791,788.30. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Walter S. Woltosz sold 18,945 shares of Simulations Plus stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $38.02, for a total transaction of $720,288.90. Following the transaction, the director now directly owns 3,641,250 shares of the company’s stock, valued at $138,440,325. The disclosure for this sale can be found here. 20.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Simulations Plus

A number of institutional investors have recently modified their holdings of the stock. Values First Advisors Inc. purchased a new position in shares of Simulations Plus in the 4th quarter valued at $1,862,000. Tributary Capital Management LLC bought a new position in Simulations Plus in the fourth quarter worth about $9,190,000. Kopion Asset Management LLC lifted its position in shares of Simulations Plus by 145.0% during the fourth quarter. Kopion Asset Management LLC now owns 122,709 shares of the technology company’s stock valued at $5,491,000 after buying an additional 72,622 shares during the last quarter. Trexquant Investment LP purchased a new stake in shares of Simulations Plus during the third quarter valued at about $1,094,000. Finally, Kornitzer Capital Management Inc. KS bought a new stake in shares of Simulations Plus in the 3rd quarter valued at about $813,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.